CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fustinoni, S.
Right arrow Articles by Colombi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fustinoni, S.
Right arrow Articles by Colombi, A.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 1082-1090, October 2002
© 2002 American Association for Cancer Research

Influence of Metabolic Genotypes on Biomarkers of Exposure to 1,3-Butadiene in Humans1

Silvia Fustinoni2, Leonardo Soleo, Margareta Warholm, Petra Begemann, Agneta Rannug, Hans-G. Neumann, James A. Swenberg, Luigi Vimercati, Vito Foà and Antonio Colombi

Dipartimento di Medicina del Lavoro, Istituti Clinici di Perfezionamento, Milano, Italy 20122 [S. F.]; Dipartimento di Medicina Interna e Medicina Pubblica, Università di Bari, Bari, Italy 70124 [L. S., L. V.]; Institute of Environmental Medicine, Karolinska Institutet and National Institute for Working Life, Stockholm, Sweden 17177 [M. W., A. R.]; Department of Toxicology, University of Würzburg, Würzburg, Germany 97078 [P. B., H-G. N.]; Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, North Carolina 27599 [P. B., J. A. S.]; and Dipartimento di Medicina del Lavoro, Università degli Studi di Milano, Milano, Italy 20122 [V. F., A. C.]

Carcinogenicity of 1,3-butadiene (BD) has been linked to its metabolic activation of genotoxic epoxides. The inherited variations in the activity of BD-metabolizing enzymes may be responsible for individual differences that modulate the effects of BD exposure. In this study, 40 Italian subjects (30 BD-exposed workers and 10 clerks) were investigated to evaluate the role of genetic polymorphism of cytochromes P450 2E1, microsomal epoxide hydrolase, glutathione transferases GSTM1, GSTP1, GSTT1, and alcohol dehydrogenase, on urinary N-acetyl-S-(3,4-hydroxybutyl)-L-cysteine (MI) and hemoglobin N-(2,3,4-trihydroxybutyl)-valine adducts (THBVal). Median urinary MI and THBVal levels were 1.71 mg/g creatinine and 37.0 pmol/g globin in BD-exposed workers (exposure range, 4–201 µg/m3) and 1.42 mg/g creatinine and 35.3 pmol/g globin in unexposed subjects. No difference between the two groups was observed. Among all subjects, MI and THBVal levels were significantly correlated (r = 0.333). Smoking positively influenced the formation of THBVal. Higher THBVal levels were found in subjects with GSTM1 null and GSTT1 null genotypes; borderline influences were also noticed for CYP2E1(G-35T). An additive effect of combined polymorphisms for CYP2E1, GSTM1, and GSTT1 genes on the THBVal levels was suggested. A multiple linear regression analysis, where each factor contributed significantly, correlated THBVal levels with smoking, CYP2E1(G-35T), GSTT1, and GSTM1 genotypes (r = 0.698). Our results indicate that the THBVal level is influenced by genotypes, and that the analysis of combined polymorphisms may be the key to a better understanding of the role played by polymorphism of BD-metabolizing enzymes.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. W. Vesper, J. T. Bernert, M. Ospina, T. Meyers, L. Ingham, A. Smith, and G. L. Myers
Assessment of the Relation between Biomarkers for Smoking and Biomarkers for Acrylamide Exposure in Humans
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2471 - 2478.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.